Poly(ethyleneimine)/arginine-glycine-aspartic acid conjugates prepared with N-succinimidyl 3-(2-pyridyldithio)propionate:: An investigation of peptide coupling and conjugate stability

被引:13
作者
Bai, J
Açan, B
Ghahary, A
Ritchie, B
Somayaji, V
Uludag, H [1 ]
机构
[1] Univ Alberta, Fac Engn, Dept Chem & Mat Engn, Edmonton, AB T6G 2G6, Canada
[2] Univ Alberta, Fac Pharm & Pharmaceut Sci, Edmonton, AB T6G 2G6, Canada
[3] Univ Alberta, Dept Surg, Fac Med & Dent, Edmonton, AB T6G 2G6, Canada
[4] Univ Alberta, Dept Haematol, Fac Med & Dent, Edmonton, AB T6G 2G6, Canada
关键词
arginine-glycine-aspartic acid (RGD); conjugation; N-succinimidyl 3-(2-pyridyldithio)propionate; (SPDP); poly(ethylene imine); stability; crosslinking; polyimides; degradation;
D O I
10.1002/pola.20472
中图分类号
O63 [高分子化学(高聚物)];
学科分类号
070305 ; 080501 ; 081704 ;
摘要
Poly(ethylene imine) (PEI), a highly cationic polymer, is being used for deoxyribonucleic acid (DNA) complexation and delivery into cells. To enhance the cellular uptake of polymer/DNA complexes, arginine-glycine-aspartic acid (RGD) peptides have been conjugated to PEI with N-succinimidyl 3-(2-pyridyldithio)propionate (SPDP). This coupling scheme creates a disulfide-linked conjugate, the stability of which in the presence of thiols is uncertain. We have investigated the conjugation of an RGD peptide, glycine-arginine-glycine-aspartic acid-serine-proline-cysteine (GRGDSPC), to PEI with SPDP and subsequently assessed the stability of the conjugates in the presence of two thiol compounds, mercaptoethanol and cysteine. SPDP effectively controls the extent of GRGDSPC substitution on PEI. The conjugates, however, are readily cleaved in the presence of the thiols; the cleavage is rapid (similar to50% cleavage in 2-4 h) and inversely related to the degree of peptide substitution on the polymers. The peptide coupling is stable in the absence of thiols, and its cleavage is strongly dependent on the pH of the medium but not on the ionic strength of the medium. We conclude that RGD peptides coupled to PEI are labile in the presence of physiological concentrations of thiols, and this should be taken into account when such polymer-peptide conjugates are used for DNA delivery. (C) 2004 Wiley Periodicals, Inc.
引用
收藏
页码:6143 / 6156
页数:14
相关论文
共 34 条
[1]   Different strategies for formation of PEGylated EGF-conjugated PEI/DNA complexes for targeted gene delivery [J].
Blessing, T ;
Kursa, M ;
Holzhauser, R ;
Kircheis, R ;
Wagner, E .
BIOCONJUGATE CHEMISTRY, 2001, 12 (04) :529-537
[2]   A VERSATILE VECTOR FOR GENE AND OLIGONUCLEOTIDE TRANSFER INTO CELLS IN CULTURE AND IN-VIVO - POLYETHYLENIMINE [J].
BOUSSIF, O ;
LEZOUALCH, F ;
ZANTA, MA ;
MERGNY, MD ;
SCHERMAN, D ;
DEMENEIX, B ;
BEHR, JP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (16) :7297-7301
[3]   Adenovirus hexon protein enhances nuclear delivery and increases transgene expression of polyethylenimine/plasmid DNA vectors [J].
Carlisle, RC ;
Bettinger, T ;
Ogris, M ;
Hale, S ;
Mautner, V ;
Seymour, LW .
MOLECULAR THERAPY, 2001, 4 (05) :473-483
[4]   The quantification of protein amino groups by the trinitrobenzenesulfonic acid method: A reexamination [J].
Cayot, P ;
Tainturier, G .
ANALYTICAL BIOCHEMISTRY, 1997, 249 (02) :184-200
[5]   Role of cross-linking agents in determining the biochemical and pharmacokinetic properties of Mgr6-clavin immunotoxins [J].
Dosio, F ;
Arpicco, S ;
Adobati, E ;
Canevari, S ;
Brusa, P ;
De Santis, R ;
Parente, D ;
Pignanelli, P ;
Negri, DRM ;
Colnaghi, MI ;
Cattel, L .
BIOCONJUGATE CHEMISTRY, 1998, 9 (03) :372-381
[6]   Gene transfer with synthetic virus-like particles via the integrin-mediated endocytosis pathway [J].
Erbacher, P ;
Remy, JS ;
Behr, JP .
GENE THERAPY, 1999, 6 (01) :138-145
[7]   ROLE OF THE CENTRAL THIOL IN DETERMINING RATES OF THE THIOL-DISULFIDE INTERCHANGE REACTION [J].
FRETER, R ;
POHL, ER ;
WILSON, JM ;
HUPE, DJ .
JOURNAL OF ORGANIC CHEMISTRY, 1979, 44 (11) :1771-1774
[8]  
Garnett MC, 1999, CRIT REV THER DRUG, V16, P147
[9]   An RGD-oligolysine peptide: A prototype construct for integrin-mediated gene delivery [J].
Harbottle, RP ;
Cooper, RG ;
Hart, SL ;
Ladhoff, A ;
McKay, T ;
Knight, AM ;
Wagner, E ;
Miller, AD ;
Coutelle, C .
HUMAN GENE THERAPY, 1998, 9 (07) :1037-1047
[10]  
JACOBSEN DW, 1994, CLIN CHEM, V40, P873